Clinical Trials Directory

Trials / Completed

CompletedNCT06029413

Myo vs. Myofascial Injection for Myofascial Trigger Points

Myo Vs. Myofascial Injection for Myofascial Trigger Points. Is There Really a Difference? A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Bozyaka Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.

Detailed description

This study aims to compare the intramuscular trigger point injection, which is traditionally used in the treatment of myofascial trigger points with the method in which facial layers are also included in the application.

Conditions

Interventions

TypeNameDescription
PROCEDUREmyo + fascial injection10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as well as for fascial layers as described.
PROCEDUREtraditional trigger point injection10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as described.

Timeline

Start date
2023-09-26
Primary completion
2024-07-25
Completion
2024-07-25
First posted
2023-09-08
Last updated
2024-08-28

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06029413. Inclusion in this directory is not an endorsement.